statistiche ricercatore

Continente	#
EU - Europa	711
NA - Nord America	566
AS - Asia	503
SA - Sud America	66
Continente sconosciuto - Info sul continente non disponibili	31
AF - Africa	24
OC - Oceania	5
Totale	1.906

Nazione	#
US - Stati Uniti d'America	546
IT - Italia	384
RU - Federazione Russa	137
SG - Singapore	136
CN - Cina	103
BD - Bangladesh	75
VN - Vietnam	65
BR - Brasile	49
HK - Hong Kong	35
KR - Corea	35
FR - Francia	28
IE - Irlanda	27
DE - Germania	24
GB - Regno Unito	23
IN - India	18
FI - Finlandia	15
NL - Olanda	13
ZA - Sudafrica	12
JP - Giappone	10
CA - Canada	8
ES - Italia	8
MX - Messico	8
SE - Svezia	8
TR - Turchia	7
UA - Ucraina	7
AT - Austria	6
DK - Danimarca	6
EC - Ecuador	6
AR - Argentina	5
BE - Belgio	5
CH - Svizzera	3
EG - Egitto	3
KE - Kenya	3
NZ - Nuova Zelanda	3
PL - Polonia	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
CR - Costa Rica	2
CZ - Repubblica Ceca	2
EE - Estonia	2
ID - Indonesia	2
IQ - Iraq	2
KZ - Kazakistan	2
LT - Lituania	2
MA - Marocco	2
NP - Nepal	2
PE - Perù	2
PK - Pakistan	2
PT - Portogallo	2
SA - Arabia Saudita	2
AU - Australia	1
BB - Barbados	1
BG - Bulgaria	1
BO - Bolivia	1
CO - Colombia	1
CU - Cuba	1
ET - Etiopia	1
HU - Ungheria	1
IL - Israele	1
KI - Kiribati	1
LK - Sri Lanka	1
MD - Moldavia	1
NG - Nigeria	1
PY - Paraguay	1
RO - Romania	1
TH - Thailandia	1
TN - Tunisia	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
ZM - Zambia	1
Totale	1.876

Nome	#
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability	330
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy	272
Exploring the selective inhibition of post-translational lysine modifier enzymes: toward new therapeutic approaches for rare disorders	230
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors	230
Traceability and authentication in agri-food production: A multivariate approach to the characterization of the Italian food excellence elephant garlic (Allium ampeloprasum L.), a vasoactive nutraceutical	200
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies	194
Targeting class I histone deacetylases triggers antitumor responses in colorectal cancer in vitro and in vivo	190
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients	168
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors	92
Totale	1.906

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	17	0	0	0	0	0	0	0	0	0	0	8	9
2022/2023	99	9	5	9	10	9	16	2	8	7	10	11	3
2023/2024	154	4	3	7	7	6	17	17	4	2	41	24	22
2024/2025	383	10	11	18	37	38	21	30	36	43	24	31	84
2025/2026	1.095	62	110	113	112	151	38	104	66	37	67	72	163
2026/2027	158	52	26	51	29	0	0	0	0	0	0	0	0
Totale													1.906